Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 11, 2009, Pages 3000-3007

  Yang, Nan ^a   Eijsink, Jasper J H ^a   Lendvai, Ágnes ^a   Volders, Haukeline H ^a   Klip, Harry ^a   Buikema, Henk J ^a   Van Hemel, Bettien M ^a   Schuuring, Ed ^a   Van Der Zee, Ate G J ^a   Wisman, G Bea A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; C13ORF18 GENE; C1ORF166 GENE; CANCER PATIENT; CCNA1 GENE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE; GYNECOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLATION; NPTX1 GENE; PAPANICOLAOU TEST; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; TFPI2 GENE; UTERINE CERVIX; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CYCLIN A1; DNA METHYLATION; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 72749123551     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0405     Document Type: Article

References (42)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-2150 (Pubitemid 46655601)
2. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1996;1288:F55-78.
3. Cervical cancer. NIH Consens Statement 1996;14:1-38.
4. Robertson JH, Woodend B. Negative cytology preceding cervical cancer: causes and prevention. J Clin Pathol 1993;46:700-702 (Pubitemid 23242417)
5. Koss LG. Cervical (Pap) smear. New directions. Cancer 1993;71:1406-1412
6. Bovicelli A, Bristow RE, Montz FJ. HPV testing: where are we now? Anticancer Res 2000;20:4673-4680
7. Sherman ME, Schiffman M, Cox JT. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 2002;94:102-107 (Pubitemid 34121289)
8. Kulasingam SL, Hughes JP, Kiviat NB, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 2002;288:1749-1757
9. Schiffman M, Khan MJ, Solomon D, et al. A study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst 2005;97:147-150 (Pubitemid 40277095)
10. Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007;7:11-22. (Pubitemid 46020844)
11. Feng Q, Balasubramanian A, Hawes SE, et al. Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst 2005;97:273-282 (Pubitemid 40310275)
12. Reesink-Peters N, Wisman GBA, Jerónimo C, et al. Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study. Mol Cancer Res 2004;2:289-295 (Pubitemid 39031078)
13. Wisman GBA, Nijhuis ER, Hoque MO, et al. Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int J Cancer 2006;119:1908-1914
14. Baylin SB, Esteller M, Rountree MR, et al. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 2001;10:687-692 (Pubitemid 32331576)
15. Jerónimo C, Henrique R, Hoque MO, et al. A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res 2004;10:8472-8478 (Pubitemid 40053412)
16. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006;6:107-116
17. Gustafson KS, Furth EE, Heitjan DF, Fansler ZB, Clark DP. DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens: an approach that utilizes receiver operating characteristic analysis. Cancer 2004;102:259-268
18. Widschwendter A, Gattringer C, Ivarsson L, et al. Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors. Clin Cancer Res 2004;10:3396-3400 (Pubitemid 38685445)
19. Sova P, Feng Q, Geiss G, et al. Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis. Cancer Epidemiol Biomarkers Prev 2006;15:114-123
20. Narayan G, Goparaju C, Arias-Pulido HH, et al. Promoter hypermethylation- mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression. Mol Cancer 2006;5:16. (Pubitemid 43959901)
21. Kahn SL, Ronnett BM, Gravitt PE, Gustafson KS. Quantitative methylation- specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests. Cancer 2008;114:57-64.
22. Lai HC, Lin YW, Huang TH, et al. Identification of novel DNA methylation markers in cervical cancer. Int J Cancer 2008;123:161-167 (Pubitemid 351705204)
23. Wentzensen N, Sherman ME, Schiffman M, Wang SS. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol 2008;112:293-299
24. Nephew KP. What will it take to obtain DNA methylation markers for early cervical cancer detection? Gynecol Oncol 2009;112:291-292
25. Suzuki H, Gabrielson E, Chen W, et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002;31:141-149 (Pubitemid 34887610)
26. Yamashita K, Upadhyay S, Osada M, et al. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2002;2:485-495 (Pubitemid 41043953)
27. Ongenaert M, Wisman GB, Volders HH, et al. Discovery of DNA methylation markers in cervical cancer using relaxation ranking. BMC Med Genomics 2008;1:57.
28. Hoque MO, Kim MS, Ostrow KL, et al. Genome-wide promoter analysis uncovers portions of the cancer methylome. Cancer Res 2008;68:2661-2670
29. Finan MA, DeCesare S, Fiorica JV, et al. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival? Gynecol Oncol 1996;62:139-147
30. Hanselaar AG. Kwaliteit van cytopathologisch onderzoek in het herziene bevolkingsonderzoek naar baarmoederhalskanker. Ned Tijdschr Obst Gynaecol 1996;109:207-210
31. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-98-3936. Leukemia 2003;17:2257-2317 (Pubitemid 38072572)
32. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation- specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-9826 (Pubitemid 26296693)
33. Jerónimo C, Henrique R, Hoque MO, et al. Quantitative RARβ2 hypermethylation: a promising prostate cancer marker. Clin Cancer Res 2004;10:4010-4014 (Pubitemid 38812475)
34. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000;132:810-819 (Pubitemid 30317797)
35. Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008;26 Suppl 10:K29-41.
36. Shivapurkar N, Sherman ME, Stastny V, et al. Evaluation of candidate methylation markers to detect cervical neoplasia. Gynecol Oncol 2007;107:549-553 (Pubitemid 350160871)
37. Wang SS, Smiraglia DJ, Wu YZ, et al. Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. Cancer Res 2008;68:2489-2497
38. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9:425-434
39. Visser J, van BD, Hoogeboom BN, et al. Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia. Int J Cancer 2006;118:2529-2537
40. Kitkumthorn N, Yanatassaneejit P, Kiatpongsan S, et al. Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer. BMC Cancer 2006;6:55.
41. Li W, Bengtson MH, Ulbrich A, et al. Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling. PLoS ONE2008;3:e1487.
42. Matsuda A, Suzuki Y, Honda G, et al. Large-scale identification and characterization of human genes that activate NF-κB and MAPK signaling pathways. Oncogene 2003;22:3307-3318 (Pubitemid 36712943)